Compare EC & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EC | HOLX |
|---|---|---|
| Founded | 1948 | 1985 |
| Country | Colombia | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Electronics |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3B | 16.6B |
| IPO Year | 2007 | 1990 |
| Metric | EC | HOLX |
|---|---|---|
| Price | $10.20 | $74.56 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 13 |
| Target Price | $9.50 | ★ $79.10 |
| AVG Volume (30 Days) | 1.8M | ★ 2.8M |
| Earning Date | 11-13-2025 | 02-04-2026 |
| Dividend Yield | ★ 9.89% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.07 | ★ 2.49 |
| Revenue | ★ $31,982,851,839.00 | $4,100,500,000.00 |
| Revenue This Year | N/A | $6.72 |
| Revenue Next Year | N/A | $5.48 |
| P/E Ratio | $142.00 | ★ $29.92 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $7.68 | $51.90 |
| 52 Week High | $11.05 | $75.34 |
| Indicator | EC | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 64.98 | 50.99 |
| Support Level | $9.20 | $74.19 |
| Resistance Level | $9.43 | $74.60 |
| Average True Range (ATR) | 0.19 | 0.18 |
| MACD | 0.07 | -0.13 |
| Stochastic Oscillator | 97.60 | 31.74 |
Ecopetrol SA is engaged in commercial and industrial activities related to the exploration, exploitation, refining, transportation, storage, distribution, and marketing of hydrocarbons, their derivatives, and products, as well as the electric power transmission services, design, development, construction, operation, and maintenance of road and energy infrastructure projects and the provision of information technology and telecommunications services. The operations of the company are performed through four business segments: Exploration and Production, Transport and Logistics, Refining and Petrochemical, and Electric Power Transmission and Toll Roads Concessions. The majority of the company's revenue is generated from the Refining and Petrochemical segment.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.